Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study

Not Applicable

Completed

• Conditions: Pain; Cancer
• Interventions: Device: Non Invasive Monitoring Device (ANI)

• Registration Number: NCT02902627
• Lead Sponsor: Hopital Foch

Brief Summary

l'ANI (Analgesia Nociception Index

The main objective of the research is to estimate the Analgesia Nociception Index (ANI) as a parameter giving the possibility of measuring the pain in painful metastatic cancer. The parameter ANI is compared with visual analogical scale (VAS) score.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08
• Primary Completion: 2016-08
• Study Completion: 2016-08
• Study First Submitted: 2016-09-13
• Study First Submitted QC: 2016-09-15
• Study First Posted: 2016-09-16
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-20
• Last Update Posted: 2018-02-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• more than 18 years, -no legal protection, -
• life expectancy is considered over 3-months
• not receiving of béta-blocking,
• Having a rhythm sinusal without extrasystole
• benefiting from a coverage by a social security system

Read More

Exclusion Criteria

• Pace-Maker
• Diabetes mellitus

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Metastatic cancer	Non Invasive Monitoring Device (ANI)	-

Primary Outcome Measures

Name	Time	Method
Comparison of the ANI parameter with the VAS	4 hours

Trial Locations

Locations (1)

Hopital Foch; 🇫🇷 Suresnes, France